The Cooper Companies, Inc. (LON:0I3I)
London · Delayed Price · Currency is GBP · Price in USD 68.34
+0.94 (1.40%)
At close: Sep 5, 2025
The Cooper Companies Market Cap
The Cooper Companies has a market cap or net worth of 10.10 billion as of September 8, 2025. Its market cap has decreased by -29.23% in one year.
Market Cap
10.10B
Enterprise Value
11.84B
Revenue
3.06B
Ranking
n/a
PE Ratio
32.75
Stock Price
68.34
Market Cap Chart
Since May 10, 1983, The Cooper Companies's market cap has increased from 264.65M to 10.10B, an increase of 3,715.98%. That is a compound annual growth rate of 8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 10.10B | -31.09% |
| Dec 31, 2024 | 14.66B | -0.40% |
| Dec 29, 2023 | 14.71B | 8.64% |
| Dec 30, 2022 | 13.54B | -11.39% |
| Dec 31, 2021 | 15.29B | 16.94% |
| Dec 31, 2020 | 13.07B | 9.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.62B |
| GSK plc | 58.98B |
| Haleon | 32.14B |
| Smith & Nephew | 12.27B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.75B |